Source:http://linkedlifedata.com/resource/pubmed/id/17481947
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6-7
|
pubmed:dateCreated |
2007-5-14
|
pubmed:abstractText |
Therapy has improved the survival of heart failure (HF) patients. However, many patients progress to advanced chronic HF (ACHF). We propose a practical clinical definition and describe the characteristics of this condition. Patients that are generally recognised as ACHF often exhibit the following characteristics: 1) severe symptoms (NYHA class III to IV); 2) episodes with clinical signs of fluid retention and/or peripheral hypoperfusion; 3) objective evidence of severe cardiac dysfunction, shown by at least one of the following: left ventricular ejection fraction<30%, pseudonormal or restrictive mitral inflow pattern at Doppler-echocardiography; high left and/or right ventricular filling pressures; elevated B-type natriuretic peptides; 4) severe impairment of functional capacity demonstrated by either inability to exercise, a 6-minute walk test distance<300 m or a peak oxygen uptake<12-14 ml/kg/min; 5) history of >1 HF hospitalisation in the past 6 months; 6) presence of all the previous features despite optimal therapy. This definition identifies a group of patients with compromised quality of life, poor prognosis, and a high risk of clinical events. These patients deserve effective therapeutic options and should be potential targets for future clinical research initiatives.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1388-9842
|
pubmed:author |
pubmed-author:AnkerStefanS,
pubmed-author:BöhmMichaelM,
pubmed-author:BerghClaes-HakanCH,
pubmed-author:BrutsaertDirkD,
pubmed-author:DargieHenryH,
pubmed-author:DicksteinKennethK,
pubmed-author:FraserAlan GAG,
pubmed-author:GavazziAntonelloA,
pubmed-author:Heart Failure Association of the European Society of Cardiology,
pubmed-author:JaarsmaTinyT,
pubmed-author:KomajdaMichelM,
pubmed-author:McMurrayJohn J VJJ,
pubmed-author:MetraMarcoM,
pubmed-author:MohacsiPaulP,
pubmed-author:PitsisAntonisA,
pubmed-author:PonikowskiPiotrP
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
684-94
|
pubmed:dateRevised |
2011-6-8
|
pubmed:meshHeading |
pubmed-meshheading:17481947-Chronic Disease,
pubmed-meshheading:17481947-Combined Modality Therapy,
pubmed-meshheading:17481947-Heart Failure,
pubmed-meshheading:17481947-Humans,
pubmed-meshheading:17481947-Prognosis,
pubmed-meshheading:17481947-Survival Rate,
pubmed-meshheading:17481947-Ventricular Dysfunction, Left
|
pubmed:articleTitle |
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.
|
pubmed:affiliation |
Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Italy. metramarco@libero.it <metramarco@libero.it>
|
pubmed:publicationType |
Journal Article,
Review
|